Both in Biotechnology
SAB Biotherapeutics vs Century Therapeutics
Over the past year SABS returned +1.1% and IPSC returned +182.5%; their daily moves had a correlation of 0.25.
SABS +1.1% IPSC +182.5%Growth of $1, one year, split-adjusted
| Metric | SABS | IPSC |
|---|---|---|
| Price | $3.29 | $1.70 |
| Market cap | $298.9M | $306.9M |
| Today | +5.29% | +11.51% |
| 1 month | +12.1% | +28.4% |
| 6 months | −13.6% | −27.6% |
| Year to date | −12.2% | +70.4% |
| 1 year | +1.1% | +182.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $99.4M | $119.7M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 75.9% |
| Short % of float | 6.2% | 23.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).